Answers are grounded in this paper and cite their sources.
This review analyzes risks and benefits of treating or observing unruptured intracranial aneurysms, highlighting complexities in decision-making.
A BSTRACT Aneurysmal subarachnoid haemorrhage is catastrophic neurological event with the primary neuroparenchymal insult and raised intracranial pressure as well rebleeding, vasospasm, cerebral ischaemia, hydrocephalus and other complications leading to high mortality and morbidity. The overall incidence of unruptured intracranial aneurysm (IA) is estimated to be about 3%. The risk of rupture, despite various predictive scales, cannot be accurately defined. Moreover, almost 5% of patients undergoing preventive intervention face severe morbidity and even death. In such a delicate situation, the decision to treat must be individualised and needs to achieve a fine balance between the estimated rupture risk and the procedural complication risk, specifically accounting for long term functional disabilities and loss of quality of life related to such an adverse event. In this review, we discuss the challenges in the decision-making process of management of unruptured IA.
No takes yet. Share an insight, caveat, or question.
Purandare et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: